CCL5 mediates CD40-driven CD4+ T cell tumor infiltration and immunity
Austin P. Huffman, Robert H. Vonderheide(Parker Institute for Cancer Immunotherapy)
Cited by 130
Related Papers
Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
|Cancer Immunology Research|2015|467
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer
|Clinical Cancer Research|2021|178
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis
|The Journal of Experimental Medicine|2020|175
Tumor cell–intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2)
|Journal of Clinical Investigation|2019|167